The Cooper Companies Inc. (COO) - NYSE
  • Thu, Jun. 2, 5:35 PM
    • Top gainers, as of 5.25 p.m.: BV +9.3%. AMBA +9.1%. AVGO +6.1%. INVN +5.3%. COO +4.9%
    • Top losers, as of 5.25p.m.: ZUMZ -9.0%. BFK -5.5%. EGO -2.3%. STO -2.3%. TCK -1.7%.
    | Thu, Jun. 2, 5:35 PM | 12 Comments
  • Apr. 21, 2014, 5:45 PM
    • Top gainers, as of 5:15 p.m.: AGN +17.5%. VRX +9.5%. NFLX +6.1%. COO +3.1%. PRGO +2.2%.
    • Top losers, as of 5:15 p.m.: RMBS -6.1%. WAT -2.7%. LEJU -2.3%. MRO -2.2%.
    | Apr. 21, 2014, 5:45 PM | 1 Comment
  • Dec. 5, 2013, 4:30 PM
    • Cooper Cos (COO): FQ4 EPS of $1.48 misses by $0.32.
    • Revenue of $411.9M (+4% Y/Y) misses by $9.68M. Shares -3.5% AH. (PR)
    | Dec. 5, 2013, 4:30 PM
  • Sep. 5, 2013, 4:27 PM
    • Cooper Cos (COO): FQ3 EPS of $1.74 beats by $0.03.
    • Revenue of $412M (+9% Y/Y) beats by $1.46M. Shares -0.26% AH. (PR)
    | Sep. 5, 2013, 4:27 PM
  • Jun. 6, 2013, 4:18 PM

    The Cooper Cos. (COO) FQ2 comes in mixed, beating on a per share basis but comes up shy on revenue. Total revenue rose 11% year-over-year, with CooperVision revenue up 7% and CooperSurgical up 32%. Gross margin rose to 66% from 64% in the prior year period. Looking forward, the company raises FY13 EPS guidance from $5.95 - $6.10 to $6.15 - $6.25. The Street is projecting $6.05. It lowers its FY13 sales outlook however, from $1.58B - $1.63B to $1.57B - $1.60B. Shares +2.5% AH.

    | Jun. 6, 2013, 4:18 PM
  • May 24, 2013, 2:34 PM
    Cooper Companies (COO +2.1%) moves up in the slipstream created from reports that its rival Bausch & Lomb is near a deal to be acquired by Valeant (VRX) for $9 billion.
    | May 24, 2013, 2:34 PM
  • Mar. 8, 2013, 12:46 PM

    Cooper Cos. (COO +3.7%) trades up on a solid FQ1 earnings beat late yesterday, as total sales climbed 16.5% year over year. Net profit also rose 37% as the company's contact-lens business continued to expand. The company revised the lower-end of its FY13 guidance, now projecting earnings in the range $5.95 - $6.10 per-share. However, that still trails analysts consensus by around $0.64. Revenue is projected to be in-line with the $1.6B Street view.

    | Mar. 8, 2013, 12:46 PM
  • Dec. 6, 2012, 4:07 PM
    Cooper Companies (COO): FQ4 EPS of $1.47 misses by $0.08. Revenue of $396.3M (+10% Y/Y) in-line. Shares -4.1% AH. (PR)
    | Dec. 6, 2012, 4:07 PM
  • Sep. 6, 2012, 4:24 PM
    More on Cooper Companies (COO): FQ3 easily beats across the board as its bottom line soars. Total revenue rose 8% Y/Y on strength in its CooperVision and CooperSurgical divisions, while net earnings were boosted by margin gains across virtually all units. The company also guides its FY higher, now expecting its EPS to be between $4.90 -$5.15 on revenue of $1.44B - $1.55B. Shares +7.8% AH.
    | Sep. 6, 2012, 4:24 PM
  • Sep. 6, 2012, 4:07 PM
    Cooper Companies (COO): FQ3 EPS of $1.45 beats by $0.16. Revenue of $378.2M (+8% Y/Y) beats by $11M. Shares +5.8% AH. (PR)
    | Sep. 6, 2012, 4:07 PM
  • Aug. 15, 2012, 1:22 PM
    Cooper Cos. (COO +4.4%) moves up after JPMorgan raised it to Overweight earlier today on valuation, citing expectations for a strong second half.
    | Aug. 15, 2012, 1:22 PM
  • Jun. 15, 2012, 11:27 AM

    Cooper Companies (COO +1.7%) moves up on an upgrade to Outperform on valation at BMO Capital, citing continuing contact lens market share gains and gross margin strength. The firm also raises its price target to $90 from $88.

    | Jun. 15, 2012, 11:27 AM
  • Jun. 8, 2012, 3:52 PM

    Baird says the weakness in Cooper Companies (COO -2%) on the back of its earnings miss is a buying opportunity. The firm notes that, despite the headlines of an earnings miss, the outlook remains unchanged and the fundamentals are still healthy. It reiterates an Outperform ratint on the shares with a $92 price target.

    | Jun. 8, 2012, 3:52 PM
  • Jun. 8, 2012, 9:05 AM
    Premarket gainers: MOH +19%. CTFO +19%. FRAN +14%. NOK +6%.
    Losers: ATPG -13%. IMUC -10%. COO -6%.
    | Jun. 8, 2012, 9:05 AM
  • Jun. 7, 2012, 4:06 PM
    Cooper Companies (COO): FQ2 EPS of $1.12 misses by $0.08. Revenue of $344.6M (+6% Y/Y) misses by $6M. Shares -5% AH. (PR)
    | Jun. 7, 2012, 4:06 PM
  • Jun. 4, 2012, 3:55 PM

    Cooper Cos. (COO -4.3%) makes a move to expand into the women's health-care market by announcing plans to acquire Danish medical-device company Origio A/S through a roughly $151M tender offer.

    | Jun. 4, 2012, 3:55 PM
Company Description
The Cooper Cos, Inc. is a medical device company. It operates through two business units: Cooper Vision and Cooper Surgical. The Cooper Vision business unit brings a refreshing perspective on vision care with a commitment to crafting quality lenses for contact lens wearers. The Cooper Surgical... More
Sector: Healthcare
Industry: Medical Instruments & Supplies
Country: United States